Form D · Biotechnology

GENE SOLUTIONS LLC

Charlottesville, VA · CIK 0001444477

Offering snapshot reported Jun 3, 2024 · SEC filing

Reported sold
$5.33M
Offering amount: $5.33M
Investors reported
12
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Dec 12, 2018
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$2.67M$5.33MDec 26, 2018: $309,879.00Dec 26, 2018Mar 25, 2020: $2,087,915.00Mar 25, 2020Mar 3, 2021: $2,300,000.00Mar 3, 2021Jun 3, 2024: $5,330,000.00Jun 3, 2024

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$2,300,000 → $5,330,000

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jun 3, 2024Amendment$5,330,000$3,030,000vs Mar 3, 202112SEC filing
Mar 3, 2021Amendment$2,300,000$212,085vs Mar 25, 202012SEC filing
Mar 25, 2020Amendment$2,087,915$1,778,036vs Dec 26, 201811SEC filing
Dec 26, 2018Initial$309,879No comparison1SEC filing
Aug 17, 2017Initial$65,000No comparison5SEC filing
Oct 2, 2015Initial$639,800No comparison2SEC filing
Feb 25, 2013Initial$298,000No comparison3SEC filing
Feb 25, 2013Initial$7,000No comparison2SEC filing
Sep 2, 2008PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-328890

Source: Form D, filed Jun 3, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Edward P. Connell Director, Executive
Susan D. Jones Director, Executive
James Oury Director
W. Davis Parker, Jr. Director, Executive
David B. Patteson Director, Executive
James C. Powers Director
Brian Warrington Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
123 E. Main Street Suite 5
Charlottesville, VA, 22902